National Bank Of Canada Neogenomics Inc Transaction History
National Bank Of Canada
- $62.9 Billion
- Q2 2024
A detailed history of National Bank Of Canada transactions in Neogenomics Inc stock. As of the latest transaction made, National Bank Of Canada holds 3,560 shares of NEO stock, worth $58,811. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,560
Previous 3,560
-0.0%
Holding current value
$58,811
Previous $55,000
10.91%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding NEO
# of Institutions
278Shares Held
127MCall Options Held
581KPut Options Held
107K-
Black Rock Inc. New York, NY19.7MShares$325 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.1MShares$233 Million0.0% of portfolio
-
Brown Advisory Inc8.77MShares$145 Million0.16% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.73MShares$111 Million0.06% of portfolio
-
Janus Henderson Group PLC London, X06.62MShares$109 Million0.05% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $2.08B
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...